Aukera Therapeutics GmbH
Basel, CH · 1 known investors
Aukera Therapeutics is a preclinical-stage biotech company, spun out of the University of Basel's Biozentrum, developing the first RAPTOR inhibitors to treat mTORC1-related diseases. It pairs mTOR pathway expertise with an AI-driven drug discovery engine aimed at complex, hard-to-drug targets.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
ST
Stefan Thomas ImsengManaging Director
Investors · 1
Frequently asked questions
- What does Aukera Therapeutics GmbH do?
- Aukera Therapeutics is a preclinical-stage biotech company, spun out of the University of Basel's Biozentrum, developing the first RAPTOR inhibitors to treat mTORC1-related diseases. It pairs mTOR pathway expertise with an AI-driven drug discovery engine aimed at complex, hard-to-drug targets.
- Who are Aukera Therapeutics GmbH's investors?
- Aukera Therapeutics GmbH's investors include Kickfund.
- Where is Aukera Therapeutics GmbH headquartered?
- Aukera Therapeutics GmbH is headquartered in Basel, CH.